Literature DB >> 29237088

Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study.

Ryusuke Yotsueda1, Shigeru Tanaka1,2, Masatomo Taniguchi3, Kiichiro Fujisaki1, Kumiko Torisu1, Kosuke Masutani1, Hideki Hirakata3, Takanari Kitazono1, Kazuhiko Tsuruya1,4.   

Abstract

Background: The contribution of the hemoglobin concentration to the incidence of hemorrhagic or ischemic stroke in patients undergoing hemodialysis is unclear.
Methods: In total, 3436 patients undergoing prevalent hemodialysis were followed up for 4 years. The primary outcome was the first development of hemorrhagic or ischemic stroke. The baseline hemoglobin concentration was divided into quartiles [hemoglobin (g/dL): Q1, ≤9.7; Q2, 9.8-10.5; Q3, 10.6-11.1; Q4, ≥11.2]. The association between the hemoglobin concentration and each type of stroke was examined using the Kaplan-Meier method and a Cox proportional hazards model.
Results: During the follow-up period, 76 (2.2%) patients developed hemorrhagic stroke and 139 (4.0%) developed ischemic stroke. The 4-year incidence rate of hemorrhagic stroke was significantly higher in patients with lower hemoglobin concentrations. Compared with the quartile of patients with the highest hemoglobin concentrations (Q4), the multivariable-adjusted hazard ratios for hemorrhagic stroke were 1.18 (95% confidence interval, 0.56-2.51), 1.59 (0.82-3.21) and 2.31 (1.16-4.73) in patients in Q3, Q2 and Q1, respectively. No association was identified between the 4-year incidence rate of ischemic stroke and the hemoglobin concentration. Compared with the quartile of patients with the lowest hemoglobin concentrations (Q1), the multivariable-adjusted hazard ratios for ischemic stroke were 1.17 (95% confidence interval, 0.73-1.89), 0.88 (0.51-1.51) and 1.10 (0.66-1.83) in patients in Q2, Q3 and Q4, respectively. Conclusions: Our results suggest that low hemoglobin concentrations are associated with a high risk of hemorrhagic stroke, but not of ischemic stroke, in patients undergoing hemodialysis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29237088     DOI: 10.1093/ndt/gfx305

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial.

Authors:  Patrick B Mark; Pardeep S Jhund; Matthew R Walters; Mark C Petrie; Albert Power; Claire White; Michele Robertson; Eugene Connolly; Stefan D Anker; Sunil Bhandari; Kenneth Farrington; Philip A Kalra; Charles R V Tomson; David C Wheeler; Christopher G Winearls; John J V McMurray; Iain C Macdougall; Ian Ford
Journal:  Kidney360       Date:  2021-09-16

Review 2.  Circulating Biomarkers in Long-Term Stroke Prognosis: A Scoping Review Focusing on the South African Setting.

Authors:  Juan Jansen van Vuuren; Somasundram Pillay; Ansuya Naidoo
Journal:  Cureus       Date:  2022-04-09

3.  Serum Alkaline Phosphatase Levels and Increased Risk of Brain Hemorrhage in Hemodialysis Patients: The Q-Cohort Study.

Authors:  Hiromasa Kitamura; Shunsuke Yamada; Hiroto Hiyamuta; Ryusuke Yotsueda; Masatomo Taniguchi; Masanori Tokumoto; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  J Atheroscler Thromb       Date:  2021-06-10       Impact factor: 4.394

4.  Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis.

Authors:  Mineaki Kitamura; Yohei Tateishi; Shuntaro Sato; Satoko Kitamura; Yuki Ota; Kumiko Muta; Hiroshi Yamashita; Tadashi Uramatsu; Yoko Obata; Yasushi Mochizuki; Masaharu Nishikido; Tsuyoshi Izumo; Takashi Harada; Satoshi Funakoshi; Takayuki Matsuo; Akira Tsujino; Hideki Sakai; Hiroshi Mukae; Tomoya Nishino
Journal:  BMC Nephrol       Date:  2019-06-07       Impact factor: 2.388

5.  Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study.

Authors:  Gunnar Toft; Uffe Heide-Jørgensen; Heleen van Haalen; Glen James; Katarina Hedman; Henrik Birn; Christian F Christiansen; Reimar W Thomsen
Journal:  J Nephrol       Date:  2019-10-05       Impact factor: 3.902

6.  Prevalence, associated factors and cardiocerebral vascular prognosis of anaemia among patients on chronic haemodialysis in South Guangdong, China.

Authors:  Mengjun Liang; Yong Wu; Ning Su; Ying Liu; Weiping Lin; Siyi Li; Weiqiang Zhong; Zongpei Jiang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

7.  Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Wen-Hsuan Tsai; Shih-Ming Chuang; Sung-Chen Liu; Chun-Chuan Lee; Ming-Nan Chien; Ching-Hsiang Leung; Shu-Jung Liu; Hong-Mou Shih
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

8.  Impact of Increased Hemoglobin on Spontaneous Intracerebral Hemorrhage.

Authors:  Yuxuan Lu; Haiqiang Jin; Yuhua Zhao; Yuxian Li; Jun Xu; Jiayu Tian; Xiaoting Luan; Siwei Chen; Wei Sun; Shouzi Zhang; Shunliang Xu; Feiqi Zhu; Luzeng Chen; Dunzhu Mima; Yongan Sun; Cidan Zhuoga
Journal:  Neurocrit Care       Date:  2021-07-27       Impact factor: 3.210

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.